锦欣生殖12月10日斥资476.6万港元回购192.55万股
JXRJXR(HK:01951) Zhi Tong Cai Jing·2025-12-10 12:52

Core Viewpoint - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Company Actions - The company plans to repurchase 1,925,500 shares at a total cost of HKD 4.766 million [1]